Molecular advances in pathogenesis of autoimmune blistering skin diseases;Advancées moléculaires dans la physiopathologie des maladies bulleuses autoimmunes

Annales de Dermatologie et de Venereologie

Volumn 132, Issue 3, 2005, Pages 231-242

  Mouquet, H ^a   Gilbert, D ^a   Musette, P ^a,b   Tron, F ^a   Joly, P ^a,b  

^a INSERM   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BULLOUS PEMPHIGOID ANTIGEN 1; COLLAGEN; DESMOGLEIN; DESMOPLAKIN; ENVOPLAKIN; LAMININ; PERIPLAKIN; PLECTIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; STRUCTURAL PROTEIN;

AUTOIMMUNITY; BLISTER; CELL ADHESION; DERMOEPIDERMAL JUNCTION; DESMOSOME; DIAGNOSTIC TEST; HUMAN; KERATINOCYTE; MOLECULAR GENETICS; PATHOGENESIS; PEMPHIGUS; PROTEIN TARGETING; REVIEW; SKIN DISEASE; AUTOIMMUNE DISEASE; IMMUNOLOGY; PATHOPHYSIOLOGY;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BLISTER; HUMANS;

EID: 17444373584     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(05)79252-8     Document Type: Review

References (74)

1. Amagai M. Adhesion molecules. I: Keratinocyte-keratinocyte interactions; cadherins and pemphigus. J Invest Dermatol 1995;104:146-52.
2. Amagai M. Autoimmunity against desmosomal cadherins in pemphigus. J Dermatol Sci 1999;20:92-102.
3. Kljuic A, Bazzi H, Sundberg JP, Martinez-Mir A, O'Shaughnessy R, Mahoney MG et al. Desmoglein 4 in hair follicle differenciation and epidermal adhesion: evidence from inherited hypotrichosis and acquired pemphigus vulgaris. Cell 2003;113:249-60.
4. Martel P, Joly P. Pemphigus: autoimmune diseases of keratinocyte's adhesion molecules. Clin Dermatol 2001;19:662-74.
5. Kazerounian S, Mahoney M G, Uitto J, Aho S. Envoplakin and periplakin, the paraneoplastic pemphigus antigens, are also recognized by pemphigus foliaceus autoantibodies. J Invest Dermatol 2000;115:505-7.
6. Nagata Y, Karashima T, Watt FM, Salmhofer W, Kanzaki T, Hashimoto T. Paraneoplastic pemphigus sera react strongly with multiple epitopes on the various regions of envoplakin and periplakin, except for C-terminal homologous domain of periplakin. J Invest Dermatol 2001;116:556-67.
7. Cozzani E, Cacciapuoti M, Parodi A. Adhesion molecules in keratinocyte. Clin Dermatol 2001;19:538-43.
8. Leung CL, Green KJ, Liem RK. Plakins: a family of versatile cytolinker proteins. Trends Cell Biol 2002;12:37-45.
9. Borradori L, Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 1999;112:411-8.
10. Ghohestani RF, Li K, Rousselle P, Uitto J. Molecular organization of the cutaneous basement membrane zone. Clin Dermatol 2001;19:551-62.
11. Hirako Y, Nishizawa Y, Sitaru C, Opitz A, Marcus K, Meyer HE et al. The 97-kDa (LABD97) and 120-kDa (LAD-1) fragments of bullous pemphigoid antigen 180/type XVII collagen have different N-termini. J Invest Dermatol 2003;121:1554-6.
12. Amagai M, Ishii K, Hashimoto T, Gamou S, Shimizu N, Nishikawa T. Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependant and glycosylation independant. J Invest Dermatol 1995;105:243-7.
13. Emery DJ, Diaz LA, Fairley JA, Lopez A, Taylor AF, Giudice GJ. Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein 1. J Invest Dermatol 1995;104:323-8.
14. Ortiz-Urda S, Elbe-Burger A, Smolle J, Marquart Y, Chudnovsky Y, Ridky TW et al. The plant lectin wheat germ agglutinin inhibits the binding of pemphigus foliaceus autoantibodies to desmoglein 1 in a majority of patients and prevents pathomechanisms of pemphigus foliaceus in vitro and in vivo. J Immunol 2003;171:6244-50.
15. Sekiguchi M, Futei Y, Fujii Y, Iwasaki T, Nishikawa T, Amagai M. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol 2001;167:5439-48.
16. Li N, Aoki V, Hans-Filho G, Rivitti EA, Diaz LA. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med 2003;197:1501-10.
17. Amagai M, Komai A, Hashimoto T, Shirakata Y, Hashimoto K, Yamada T, et al. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 1999;140:351-357.
18. Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S et al. Characterization of autoantibodies in pemphigus using antigen-specific ELISAs with baculovirus expressed recombinant desmogleins. J Immunol 1997;159:2010-7.
19. Cheng SW, Kobayashi M, Kinoshita-Kuroda K, Tanikawa A, Amagai M et al. Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3. Br J Dermatol 2002;147:261-5.
20. Amagai M, Nishikawa T, Nousari HC, Anhalt GJ, Hashimoto T. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 1998;102:775-82.
21. Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA. Induction of pemphigus in neonatal mice by passive transfert of IgG from patients with the disease. N Engl J Med 1982;306:1189-96.
22. Fan JL, Memar O, McCormick DJ, Prabhakar BS. BALB/c mice produce blister-causing antibodies upon immunization with a recombinant human desmoglein 3. J Immunol 1999;163:6628-35.
23. Amagai M, Tsunoda K, Suzuki H, Nishifuji K, Koyasu S, Nishikawa T. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J Clin Invest 2000;105:625-31.
24. Ohyama M, Amagai M, Tsunoda K, Ota T, Koyasu S, Hata J et al. Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris. J Invest Dermatol 2002;118:199-204.
25. Tsunoda K, Ota T, Suzuki H, Ohyama M, Nagai T, Nishikawa T et al. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris. Eur J Immunol 2002;32:627-33.
26. Tsunoda K, Ota T, Aoki M, Yamada T, Nagai T, Nakagawa T et al. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 2003;170:2170-8.
27. Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profiles. J Am Acad Dermatol 1999;40:167-70.
28. Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR. Explanations for clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999;103:461-8.
29. Wu H, Wang ZH, Yan A, Lyle S, Fakharzadeh S, Wahl JK et al. Protection against pemphigus foliaceus by desmoglein 3 in neonates. N Engl J Med 2000;343:31-5.
30. Vu TN, Lee TX, Ndoye A, Shultz LD, Pittelkow MR, Dahl MV et al. The pathophysiological significance of nondesmoglein targets of pemphigus autoimmunity. Development of antibodies against keratinocyte cholinergic receptors in patients with pemphigus vulgaris and pemphigus foliaceus. Arch Dermatol 1998;134:971-80.
31. Nguyen VT, Ndoye A, Grando SA. Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity. Am J Pathol 2000;157:1377-91.
32. Nguyen VT, Ndoye A, Grando SA. Pemphigus vulgaris antibody identifies pemphaxin. A novel keratinocyte annexin-like molecule binding acetylcholine. J Biol Chem 2000;275:29466-76.
33. Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest 2000;106:1467-79.
34. Kitajima Y, Aoyama Y, Seishima M. Transmembrane signaling for adhesive regulation of desmosomes and hemidesmosomes, and for cell-cell detachment induced by pemphigus IgG in cultured keratinocytes: involvement of protein kinase C. J Invest Dermatol Symp Proc 1999;4:137-44.
35. Aoyama Y, Owada MK, Kitajima Y. A pathogenic autoantibodies, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes. Eur J Immunol 1999;29:2233-40.
36. Nguyen VT, Arredondo J, Chernyavsky AI, Kitajima Y, Pittelkow M, Grando SA. Pemphigus vulgaris IgG and methylprednisolone exhibit reciprocal effects on keratinocytes. J Biol Chem 2004;279:2135-46.
37. Wang X, Bregegere F, Frusic-Zlotkin M, Feinmesser M, Michel B, Milner Y. Possible apoptotic mechanism in epidermal cell acantholysis induced by pemphigus vulgaris autoimmunoglobulins. Apoptosis 2004;9:131-43.
38. Pelacho B, Natal C, Espana A, Sanchez-Carpintero I, Iraburu MJ, Lopez-Zabalza MJ. Pemphigus vulgaris autoantibodies induce apoptosis in HaCaT keratinocytes. FEBS Lett 2004;566:6-10.
39. Kanitakis J. Indirect immunofluorescence microscopy for the serological diagnostics of autoimmune blistering skin diseases: a review. Clin Dermatol 2001;19:614-21.
40. Reunala TL. Dermatitis herpetiformis. Clin Dermatol 2001;19:728-36.
41. Zillikens D, Rose PR, Balding SD, Liu Z, Olague-Marchan M, Diaz LA et al. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 1997;109:573-9.
42. Nakatani C, Muramatsu T, Shirai T. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins. Br J Dermatol 1998;139:365-70.
43. Kobayashi M, Amagai M, Kuroda-Kinoshita K, Hashimoto T, Shirakata Y, Hashimoto K et al. BP180 ELISA using bacterial recombinant NC16A protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 2002;30:224-32.
44. Chimanovitch I, Schmidt E, Messer G, Dopp R, Ciudice GJ, Brocker EB et al. IgG1 and IgG3 are the major immunoglobulin subclasses targeting epitopes within BP180 NC16A in pemphigoid gestationis. J Invest Dermatol 1999;113:140-2.
45. Balding SD, Prost C, Diaz LA, Bernard P, Bedane C, Aberdam D et al. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 1996;106:41-6.
46. Zillikens D, Herzele K, Georgi M, Schmidt E, Chimanovitch I, Schumann H et al. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP180. J Invest Dermatol 1999;113:947-53.
47. Schumann H, Baetge J, Tasanen K, Wojnarowska F, Schäcke H, Zillikens D et al. The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol 2000;156:685-95.
48. Allen J, Wojnarowska F. Linear IgA disease: the IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults. Br J Dermatol 2003;149:977-85.
49. Skaria M, Jaunin F, Hunziker T, Riou S, Schumann H, Bruckner-Tuderman L et al. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230. J Invest Dermatol 2000;114:998-1004.
50. Delaporte E, Dubost-Brama A, Ghohestani R, Nicolas JF, Neyrink JL, Bergoend H et al. IgE autoantibodies directed against the major bullous pemphigoid antigen in patients with a severe form of pemphigoid. J Immunol 1996;157:3642-7.
51. Dimson OG, Giudice GJ, Fu CL, Van den Bergh F, Warren SJ, Janson MM et al. Identification of a potentiel effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid. J Invest Dermatol 2003;120:784-8.
52. Lazarova Z, Hsu R, Yee C, Yancey KB. Antiepiligrin cicatricial pemphigoid represents an autoimmune response to subunits present in laminin 5 (α3β3γ2). Br J Dermatol 1998;139:791-7.
53. Bhol KC, Dans MJ, Simmons RK, Foster CS, Giancotti FG, Ahmed AR. The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4. J Immunol 2000;165:2824-9.
54. Lapiere JC, Woodley DT, Parente MG, Iwasaki T, Wynn KC, Christiano AM et al. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993;92:1831-9.
55. Chen M, Chan LS, Cai X, O'Toole EA, Sample JC, Woodley DT. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 1997;108:68-72.
56. Tanaka H, Yamamoto AI, Hashimoto T, Hiramoto K, Harada T, Kawachi Y et al. A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen. Lab Invest 1997;77:623-32.
57. Chen M, Keene DR, Costa FK, Tahk SH, Woodley DT. The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis bullosa acquisita autoantibodies. J Biol Chem 2001;276:21649-55.
58. Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002;195:747-57.
59. Hitomi K, Presland RB, Nakayama T, Fleckman P, Dale BA, Maki M. Analysis of epidermal-type transglutaminase (transglutaminase 3) in human stratified epithelia and cultured keratinocytes using monoclonal antibodies. J Dermatol Sci 2003;32:95-103.
60. Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993;92:2480-8.
61. Liu Z, Diaz LA, Swartz SJ, Troy JL, Fairley JA, Giudice GJ. Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid. J Immunol 1995;155:5449-54.
62. Liu Z, Giudice GJ, Swartz SJ, Fairley JA, Till GO, Troy JL et al. The role of complement in experimental bullous pemphigoid. J Clin Invest 1995;95:1539-44.
63. Liu Z, Giudice GJ, Zhou X, Swartz SJ, Troy JL, Fairley JA et al. A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest 1997;100:1256-63.
64. Liu Z, Shipley JM, Vu TH, Zhou X, Diaz LA, Werb Z et al. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med 1998;188:475-82.
65. Liu Z, Shapiro SD, Zhou X, Twining SS, Senior RM, Giudice GJ et al. A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest 2000;105:113-23.
66. Chen R, Ning G, Zhao M-L, Fleming MG, Diaz LA, Werb Z et al. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest 2001;108:1151-58.
67. Chen R, Fairley JA, Zhao M-L, Giudice GJ, Zillikens D, Diaz LA et al. Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation. J Immunol 2002;169:3987-92.
68. Zone JJ, Egan CA, Taylor TB, Meyer LJ. IgA autoimmune disorders: development of a passive transfer mouse model. J Investig Dermatol Symp Proc 2004;9:47-51.
69. Lazarova Z, Yee C, Darling T, Briggaman RA, Yancey KB. Passive transfert of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest 1996;98:1509-18.
70. Lazarova Z, Hsu R, Yee C, Yancey KB. Human anti-laminin 5 autoantibodies induce subepidermal blisters in an experimental human skin graft model. J Invest Dermatol 2000;114:178-84.
71. Bhol KC, Colon JE, Ahmed AR. Autoantibody in mucous membrane pemphigoid binds to an intracellular epitope on human beta4 integrin and causes basement membrane zone separation in oral mucosa in an organ culture model. J Invest Dermatol 2003;120:701-2.
72. Chan RY, Bhol K, Tesavibul N, Letko E, Simmons RK, Foster CS et al. The role of antibody to human beta4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1999;40:2283-90.
73. Sitaru C, Kromminga A, Hashimoto T, Brocker EB, Zilligens D. Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol 2002;161:301-11.
74. Ghohestani RF. Pathogenic effects of auto-antibodies in skin diseases. In: JF Nicolas, J Thivolet, eds. Immunodermatology. Paris:John Libbey Eurotext, 1998:185-200.